Hiddo Lambers Heerspink is Professor of Clinical Trials and Personalized Medicine and a clinical pharmacologist/trialist at the Department of Clinical Pharmacy and Pharmacology University Medical Center  Groningen, The Netherlands. He studied pharmacy at the University of Groningen and subsequently received his PhD from the University Medical Center Groningen. He worked as  Postdoctoral Fellow at The George Institute for Global Health, Sydney, Australia, where he investigated the effects of blood pressure-lowering regimens on renal and cardiovascular outcomes in patients with chronic kidney disease. Prof. Heerspink’s research interests focus on optimising current treatment strategies and finding new therapeutic approaches to halt the progression of renal and cardiovascular diseases in patients with diabetes. His particular interest in clinical research is to identify determinants of individual treatment responses and ways to optimise drug response in individual patients. He is active in clinical trials focused on renal and cardiovascular complications of Type 2 diabetes. His main expertise includes clinical trial design and personalised medicine, as well as the methodological aspects and statistical analyses of clinical trials.